Taylor Wealth Management Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$396K Sell
4,341
-2
-0% -$177 0.23% 48
2022
Q1
$356K Sell
4,343
-350
-7% -$27.6K 0.14% 54
2021
Q4
$360K Buy
4,693
+1,379
+42% +$110K 0.13% 53
2021
Q3
$249K Buy
+3,314
New +$252K 0.09% 63
2019
Q1
Sell
-1,893
Closed -$138K 90
2018
Q4
$138K Hold
1,893
0.08% 45
2018
Q3
$128K Sell
1,893
-5
-0.3% -$319 0.05% 60
2018
Q2
$110K Hold
1,898
0.05% 61
2018
Q1
$99K Sell
1,898
-1,048
-36% -$56.6K 0.05% 64
2017
Q4
$158K Hold
2,946
0.07% 67
2017
Q3
$180K Hold
2,946
0.08% 67
2017
Q2
$180K Hold
2,946
0.08% 65
2017
Q1
$179K Sell
2,946
-105
-3% -$6.37K 0.08% 66
2016
Q4
$171K Hold
3,051
0.08% 63
2016
Q3
$182K Sell
3,051
-105
-3% -$6.14K 0.08% 55
2016
Q2
$173K Sell
3,156
-524
-14% -$27.9K 0.07% 51
2016
Q1
$186K Buy
3,680
+53
+1% +$2.6K 0.09% 42
2015
Q4
$183K Sell
3,627
-827
-19% -$41.7K 0.08% 50
2015
Q3
$210K Hold
4,454
0.1% 41
2015
Q2
$242K Buy
4,454
+1,489
+50% +$83.5K 0.08% 49
2015
Q1
$163K Buy
+2,965
New +$168K 0.05% 56

Other funds holding MRK

Taylor Wealth Management Partners's MRK Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Merck (MRK) stake by 0.05% in Q2 2022, selling an estimated $177 and leaving 4,341 shares worth $396K. The position accounts for 0.23% of the portfolio, ranked #48.

Taylor Wealth Management Partners first reported a position in MRK in Q1 2015 and has held it in 20 quarters since. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Taylor Wealth Management Partners held 4,341 shares of Merck worth $396K as of Q2 2022.
  • Taylor Wealth Management Partners sold 2 Merck shares in Q2 2022, an estimated $177.
  • Merck made up 0.23% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #48 holding.
  • Taylor Wealth Management Partners first reported a position in Merck in Q1 2015 and has held it in 20 quarters since.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.